Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

NCT01082562 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis
Hypercholesterolemia

Interventions

DRUG: BMS-844421
DRUG: 0.9% sodium chloride injection solution

Sponsor

Bristol-Myers Squibb